Goat anti-Human Apolipoprotein a

• Description:

  Goat anti-Human Apolipoprotein a_x000D_ Catalog number: B2010225_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Volume/Weight: 50 ug_x000D_ pH: na_x000D_ Supplied as: Ready-to-use_x000D_ Appearance: Solution_x000D_ Applications: High purity monoclonal antibody to human Apolipoprotein a. This antibody has been validated in ELISA, IHC, WB and other immunoassay applications._x000D_ Storage: -20°C_x000D_ Keywords: Apo(a) antibody_x000D_ Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Saleheen D, Haycock PC, Zhao W, Rasheed A, Taleb A, Imran A, Abbas S, Majeed_x000D_ F, Akhtar S, Qamar N, Zaman KS, Yaqoob Z, Saghir T, Rizvi SNH, Memon A, Mallick_x000D_ NH, Ishaq M, Rasheed SZ, Memon FU, Mahmood K, Ahmed N, Frossard P, Tsimikas S,_x000D_ Witztum JL, Marcovina S, Sandhu M, Rader DJ, Danesh J. Apolipoprotein(a) isoform_x000D_ size, lipoprotein(a) concentration, and coronary artery disease: a mendelian_x000D_ randomisation analysis. Lancet Diabetes Endocrinol. 2017 Jul;5(7):524-533._x000D_ _x000D_ 2: Viney NJ, van Capelleveen JC, Geary RS, Xia S, Tami JA, Yu RZ, Marcovina SM,_x000D_ Hughes SG, Graham MJ, Crooke RM, Crooke ST, Witztum JL, Stroes ES, Tsimikas S._x000D_ Antisense oligonucleotides targeting apolipoprotein(a) in people with raised_x000D_ lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging_x000D_ trials. Lancet. 2016 Nov 5;388(10057):2239-2253._x000D_ _x000D_ 3: Ma L, Chan DC, Ooi EMM, Marcovina SM, Barrett PHR, Watts GF._x000D_ Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma_x000D_ Lipoprotein(a) Concentration. J Clin Endocrinol Metab. 2019 Dec_x000D_ 1;104(12):6247-6255._x000D_ _x000D_ 4: Tmoyan NA, Ezhov MV, Afanasieva OI, Klesareva EA, Razova OA, Kukharchuk VV,_x000D_ Pokrovsky SN. The association of lipoprotein(a) and apolipoprotein(a) phenotypes_x000D_ with peripheral artery disease. Ter Arkh. 2018 Sep 20;90(9):31-36._x000D_ _x000D_ 5: Noureen A, Ronke C, Khalifa M, Halbwax M, Fischer A, André C, Atencia R,_x000D_ Garriga R, Mugisha L, Ceglarek U, Thiery J, Utermann G, Schmidt K. Significant_x000D_ differentiation in the apolipoprotein(a)/lipoprotein(a) trait between_x000D_ chimpanzees from Western and Central Africa. Am J Primatol. 2017 Sep;79(9)._x000D_ _x000D_ 6: Enkhmaa B, Anuurad E, Zhang W, Kim K, Berglund L. Heritability of_x000D_ apolipoprotein (a) traits in two-generational African-American and Caucasian_x000D_ families. J Lipid Res. 2019 Sep;60(9):1603-1609._x000D_ _x000D_ 7: Yahya R, Berk K, Verhoeven A, Bos S, van der Zee L, Touw J, Erhart G,_x000D_ Kronenberg F, Timman R, Sijbrands E, Roeters van Lennep J, Mulder M. Statin_x000D_ treatment increases lipoprotein(a) levels in subjects with low molecular weight_x000D_ apolipoprotein(a) phenotype. Atherosclerosis. 2019 Oct;289:201-205._x000D_ _x000D_ 8: Tsimikas S, Fazio S, Viney NJ, Xia S, Witztum JL, Marcovina SM. Relationship_x000D_ of lipoprotein(a) molar concentrations and mass according to lipoprotein(a)_x000D_ thresholds and apolipoprotein(a) isoform size. J Clin Lipidol. 2018 Sep-_x000D_ Oct;12(5):1313-1323._x000D_ _x000D_ Products Related to Goat anti-Human Apolipoprotein a: Biochemical Buffers and Solutions

• Short Description:

  Catalog Number: B2010225 (50 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4